Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial

Daniel J. Wallace, Vibeke Strand, Joan T. Merrill, Serghei Popa, Alberto J. Spindler, Alicia Eimon, Michelle Petri, Josef S. Smolen, Joseph Wajdula, Jared Christensen, Cheryl Li, Annette Diehl, Michael S. Vincent, Jean Beebe, Paul Healey, Sudhakar Sridharan

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds